GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,859,000 | +118.8% | 56,676 | +2.6% | 0.00% | +100.0% |
| Q2 2022 | $1,764,000 | -1.3% | 55,231 | +7.0% | 0.00% | 0.0% |
| Q1 2022 | $1,788,000 | +22.9% | 51,616 | +3.9% | 0.00% | – |
| Q4 2021 | $1,455,000 | +13.8% | 49,698 | -0.8% | 0.00% | – |
| Q3 2021 | $1,278,000 | -5.1% | 50,123 | +30.4% | 0.00% | – |
| Q2 2021 | $1,346,000 | -18.0% | 38,443 | -4.6% | 0.00% | -100.0% |
| Q1 2021 | $1,642,000 | +3.8% | 40,297 | +10.3% | 0.00% | 0.0% |
| Q4 2020 | $1,582,000 | -40.3% | 36,518 | -24.1% | 0.00% | 0.0% |
| Q3 2020 | $2,652,000 | -13.1% | 48,099 | -0.5% | 0.00% | 0.0% |
| Q2 2020 | $3,051,000 | +73.4% | 48,323 | +40.3% | 0.00% | 0.0% |
| Q1 2020 | $1,760,000 | -40.2% | 34,442 | -7.0% | 0.00% | 0.0% |
| Q4 2019 | $2,944,000 | +101.5% | 37,040 | +23.0% | 0.00% | 0.0% |
| Q3 2019 | $1,461,000 | +4.2% | 30,120 | +13.0% | 0.00% | 0.0% |
| Q2 2019 | $1,402,000 | +16.4% | 26,666 | +17.2% | 0.00% | 0.0% |
| Q1 2019 | $1,204,000 | +34.7% | 22,745 | +4.4% | 0.00% | 0.0% |
| Q4 2018 | $894,000 | +30.3% | 21,779 | +20.6% | 0.00% | – |
| Q3 2018 | $686,000 | -5.8% | 18,065 | +12.3% | 0.00% | -100.0% |
| Q2 2018 | $728,000 | -1.5% | 16,092 | +5.2% | 0.00% | 0.0% |
| Q1 2018 | $739,000 | +99.2% | 15,299 | +63.5% | 0.00% | – |
| Q4 2017 | $371,000 | +24.1% | 9,357 | -4.3% | 0.00% | – |
| Q3 2017 | $299,000 | +16.8% | 9,775 | +4.9% | 0.00% | – |
| Q2 2017 | $256,000 | +43.8% | 9,315 | +93.4% | 0.00% | – |
| Q1 2017 | $178,000 | +187.1% | 4,816 | +10.1% | 0.00% | – |
| Q4 2016 | $62,000 | +31.9% | 4,376 | +106.0% | 0.00% | – |
| Q3 2016 | $47,000 | -36.5% | 2,124 | -52.9% | 0.00% | – |
| Q2 2016 | $74,000 | – | 4,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |